BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 23568356)

  • 1. Treatments for esophageal cancer: a review.
    Kato H; Nakajima M
    Gen Thorac Cardiovasc Surg; 2013 Jun; 61(6):330-5. PubMed ID: 23568356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for esophageal squamous cell carcinoma.
    Nakajima M; Kato H
    Expert Opin Pharmacother; 2013 Jul; 14(10):1345-54. PubMed ID: 23675862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in multidisciplinary treatment for patients with esophageal cancer.
    Watanabe M; Otake R; Kozuki R; Toihata T; Takahashi K; Okamura A; Imamura Y
    Surg Today; 2020 Jan; 50(1):12-20. PubMed ID: 31535225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy.
    Niwa Y; Koike M; Fujimoto Y; Oya H; Iwata N; Nishio N; Hiramatsu M; Kanda M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y
    Dis Esophagus; 2016 Aug; 29(6):598-602. PubMed ID: 26338205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.
    von Döbeln GA; Klevebro F; Jacobsen AB; Johannessen HO; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M
    Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30137281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Video-assisted laparoscopic resection of the esophagus for carcinoma after neoadjuvant therapy.
    Aujesky R; Neoral C; Kral V; Bohanes T; Vrba R; Vomackova K
    Hepatogastroenterology; 2009; 56(93):1035-8. PubMed ID: 19760936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma.
    Murakami Y; Hamai Y; Emi M; Hihara J; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Kimura T; Okada M; Nagata Y
    J Radiat Res; 2018 Sep; 59(5):616-624. PubMed ID: 29939306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results of neoadjuvant chemoradiotherapy followed by radical esophagectomy in patients with initially inoperable thoracic esophageal cancer.
    Morimoto H; Fujiwara Y; Lee S; Amano K; Hosono M; Miki Y; Osugi H
    Jpn J Radiol; 2018 Jan; 36(1):23-29. PubMed ID: 29080946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgery or definitive chemoradiotherapy in management of localized squamous cell carcinoma of esophagus - What is the verdict?
    Hngorani M; Jain P
    Crit Rev Oncol Hematol; 2023 Oct; 190():104111. PubMed ID: 37660931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
    Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
    Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy.
    Takeuchi H; Saikawa Y; Oyama T; Ozawa S; Suda K; Wada N; Takahashi T; Nakamura R; Shigematsu N; Ando N; Kitajima M; Kitagawa Y
    World J Surg; 2010 Feb; 34(2):277-84. PubMed ID: 20033687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma.
    Akiyama Y; Iwaya T; Endo F; Chiba T; Takahara T; Otsuka K; Nitta H; Koeda K; Mizuno M; Kimura Y; Sasaki A
    Surg Endosc; 2018 Jan; 32(1):391-399. PubMed ID: 28664431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.
    Straatman J; van der Wielen N; Nieuwenhuijzen GA; Rosman C; Roig J; Scheepers JJ; Cuesta MA; Luyer MD; van Berge Henegouwen MI; van Workum F; Gisbertz SS; van der Peet DL
    Surg Endosc; 2017 Jan; 31(1):119-126. PubMed ID: 27129563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal treatment for resectable esophageal cancer.
    Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Mori M; Doki Y
    Gen Thorac Cardiovasc Surg; 2011 Jul; 59(7):461-6. PubMed ID: 21751104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].
    Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Shirouzu K; Yamana H; Toda Y; Hayabuchi N
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2016-22. PubMed ID: 11103231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.